Journals / Solunum Hastalıkları / 2004 / Cilt: 15 - Sayı: 4

The diagnostic value of vascular endothelial growth factor in pleural effusion

Plevral efüzyonun ayırıcı tanısında "Vasküler endotelyal 'Growth' faktör"ün tanısal değeri

Pages
170–175
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, it was thought that VEGF might play an important role in the formation of exudative effusions especially with malignant origin.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this prospective study, our aim was to assess the usefullness of vascular endothelial growth factor (VEGF) in diagnosis of patients with pleural effusions.
📊
Key Findings & Data:The levels of VEGF in pleural fluids from 100 patients with pleural effusions of varying origins were examined.
💡
Conclusion & Impact:In conclusion, it was thought that VEGF might play an important role in the formation of exudative effusions especially with malignant origin.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Plevral efüzyon · Akciğer neoplazmları · Tanı

Abstract

In this prospective study, our aim was to assess the usefullness of vascular endothelial growth factor (VEGF) in diagnosis of patients with pleural effusions. The levels of VEGF in pleural fluids from 100 patients with pleural effusions of varying origins were examined. The VEGF levels of pleural fluids of 100 patients with mean age of 56.59 ± 15.47 years were measured with an enzyme-linked immunosorbent assay. The median level of VEGF in the exudative effusions (513.38 ± 583.30 pg/mL) was significantly higher than the median level of VEGF in the transudative effusions (49.17 ± 73.98 pg/mL, p< 0.05). Malignant pleural effusions (885.50 ± 616.70 pg/mL) contained significantly higher levels of VEGF than benign pleural effusions (228.86 ± 409.85 pg/mL, p< 0.05). The median level of VEGF in the malignant effusions was also significantly higher than the median level of VEGF in the paramalignant effusions. There were no significant differences between pleural fluid VEGF levels of different histological subtypes of lung cancer (p> 0.05). In conclusion, it was thought that VEGF might play an important role in the formation of exudative effusions especially with malignant origin. We need further controlled studies to evaluate the value of VEGF in the diagnosis of pleural effusion.

Özet

Bu prospektif çalışmada, plevral sıvının ayırıcı tanısında "vasküler endotelyal 'growth' faktör (VEGF)"ün kullanılabilirliğinin değerlendirilmesi amaçlandı. Değişik etyolojiye sahip 100 plevral sivili hastanın plevral sıvı ve serum VEGF düzeyleri ELISA yöntemi ile ölçüldü. Tüm olguların yaş ortalamaları 56.59 ± 15.47 yıl idi. Eksüdatif sivili hastaların ortalama plevral sıvı VEGF düzeyleri (513.38 ± 583.30 pg/mL), transüdatif sivili olanlara göre (49.17 ± 73.98 pg/mL) anlamlı olarak yüksek bulundu (p 0.05). Sonuç olarak, çalışmamızda VEGF'nin özellikle malign plevral sıvılar olmak üzere eksüda niteliğindeki sıvıların oluşmasında rolü olabileceği düşünüldü. Ayrıca VEGF'nin plevral efüzyonlarda tanıya katkısının değerlendirilmesi için geniş kapsamlı çalışmaların yapılması gerektiği sonucuna varıldı.

🔖

Cite This Article

BAKIRCI, T., ALPAR, S., UÇAR, N., TURGUT, A. S., DURSUN, B., SERTKAYA, D., KURT, B. (2004). The diagnostic value of vascular endothelial growth factor in pleural effusion. Solunum Hastalıkları, Cilt: 15 - Sayı: 4, 170–175. https://ajindex.com/articles/318542

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Bartter T, Santarelli R, Akers S, Pratter M. The evaluation of pleural effusion. Chest 1994;106:1209-14
  2. Sahn SA. Approach to the patients with a pleural effusion. In: Light RW, Lee YC, eds. Textbook of pleural diseases. 1st ed. Great Britain: Hodder Headline Group, 2003;183-90
  3. Light RW, Macgregor MI, Luchsinger PC, et al. Pleural effusions: the diagnostic seperation of transudates and exudates. Ann Intern Med 1972;77:507-13
  4. Romero S, Candela A, Martin C, et al. Evaluation of different criteria for the seperation of pleural transudates from exudates. Chest 1993;104:399-404
  5. Kraft A, Weindel K, Ochs A. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer 1999;85:178-87
  6. Thickett DR, Armstrong L, Millar AB. Vascular endothelial growth factor in inflammatory and malignant pleural effusions. Thorax 1999;54:707-10
  7. Cheng D, Rodriguez RM, Perkett EA. Vascular endothelial growth factor in pleural fluid. Chest 1999;116:760-5
  8. Ikubo A, Morisaki T, Katano M, et al. A possible role of TGF-beta in the formation of malignant effusions. Clin Immunol Immunopathol 1995;77:27-32
  9. Worrall NK, Chang K, LeJeune WS, et al. TNF-alpha causes reversible in vivo systemic vasculer barrier dysfunction via NO-dependent and independent mechanisms. Am J Physiol 1997;273:2565-74
  10. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 1986;46:5629
  11. Losley JB. Comparative analysis of the biochemical parameters used to distinguish between pleural transudates and exudates. Chest 1995;107:1604-9
  12. Atabey F, Yılmaz U, Can H ve ark. Plevral sıvıların ayırıcı tanısında Light kriterlerinin değeri. Solunum Hastalıkları 1993;4:15-20
  13. Hiroaki Y, Eiji T, Yoshihiro S. Vascular endothelial growth factor in malignant pleural effusions associated with lung cancer. Cancer Immunol Immunother 1999;48:396-400
  14. Andrea K, Karin W, Andreas O. Vascular endothelial growth factor in the sera and effusions with malignant and nonmalignant disease. Cancer 1999;85:178-87
  15. Yeo KT, Wang HH, Nagy JA. Vascular permeability factor in guinea pig and human tumor and inflammatory effusions. Cancer Res 1993;53:291
  16. Cheng D, Lee YCG, Rogers JT. Vascular endothelial growth factor level correlates with transforming growth factor-ß isoform levels in pleural effusions. Chest 2000;118:1747-53
  17. Takiga